These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Characterization of an eukaryotic peptide deformylase from Plasmodium falciparum. Bracchi-Ricard V; Nguyen KT; Zhou Y; Rajagopalan PT; Chakrabarti D; Pei D Arch Biochem Biophys; 2001 Dec; 396(2):162-70. PubMed ID: 11747293 [TBL] [Abstract][Full Text] [Related]
50. Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase. Grant SK; Green BG; Kozarich JW Bioorg Chem; 2001 Aug; 29(4):211-22. PubMed ID: 16256693 [TBL] [Abstract][Full Text] [Related]
51. Theoretical study of Escherichia coli peptide deformylase inhibition by several drugs. Chikhi A; Bensegueni A; Boulahrouf A; Bencharif M In Silico Biol; 2006; 6(5):459-66. PubMed ID: 17274774 [TBL] [Abstract][Full Text] [Related]
52. UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) inhibitors: a new class of antibacterial agents. Zhang J; Zhang L; Li X; Xu W Curr Med Chem; 2012; 19(13):2038-50. PubMed ID: 22414079 [TBL] [Abstract][Full Text] [Related]
53. Understanding the highly efficient catalysis of prokaryotic peptide deformylases by shedding light on the determinants specifying the low activity of the human counterpart. Fieulaine S; Desmadril M; Meinnel T; Giglione C Acta Crystallogr D Biol Crystallogr; 2014 Feb; 70(Pt 2):242-52. PubMed ID: 24531459 [TBL] [Abstract][Full Text] [Related]
54. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents. Calí P; Naerum L; Mukhija S; Hjelmencrantz A Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716 [TBL] [Abstract][Full Text] [Related]
55. Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition. Thorarensen A; Deibel MR; Rohrer DC; Vosters AF; Yem AW; Marshall VD; Lynn JC; Bohanon MJ; Tomich PK; Zurenko GE; Sweeney MT; Jensen RM; Nielsen JW; Seest EP; Dolak LA Bioorg Med Chem Lett; 2001 Jun; 11(11):1355-8. PubMed ID: 11378353 [TBL] [Abstract][Full Text] [Related]
56. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery. Sharma A; Khuller GK; Sharma S Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983 [TBL] [Abstract][Full Text] [Related]
57. Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor. Pratt LM; Beckett RP; Davies SJ; Launchbury SB; Miller A; Spavold ZM; Todd RS; Whittaker M Bioorg Med Chem Lett; 2001 Oct; 11(19):2585-8. PubMed ID: 11551755 [TBL] [Abstract][Full Text] [Related]
58. Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates. Jones RN; Moet GJ; Sader HS; Fritsche TR J Antimicrob Chemother; 2004 May; 53(5):804-7. PubMed ID: 15056649 [TBL] [Abstract][Full Text] [Related]
59. Peptide deformylases from Vibrio parahaemolyticus phage and bacteria display similar deformylase activity and inhibitor binding clefts. Grzela R; Nusbaum J; Fieulaine S; Lavecchia F; Desmadril M; Nhiri N; Van Dorsselaer A; Cianferani S; Jacquet E; Meinnel T; Giglione C Biochim Biophys Acta Proteins Proteom; 2018 Feb; 1866(2):348-355. PubMed ID: 29101077 [TBL] [Abstract][Full Text] [Related]
60. Identification of a new peptide deformylase gene from enterococcus faecium and establishment of a new screening model targeted on PDF for novel antibiotics. Tang XB; Si SY; Zhang YQ Biomed Environ Sci; 2004 Sep; 17(3):350-8. PubMed ID: 15602833 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]